- JP-listed companies
- NANO MRNA Co.,Ltd.
NANO MRNA Co.,Ltd.JP:4571
Market cap
¥13.7B
P/E ratio
| Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | |
| Net sales | 374 | 472 | 676 | 243 | 219 | 259 | 497 | 553 | 313 | 264 | 202 | 136 |
| Cost of sales | 273 | 182 | 212 | 32 | 61 | 68 | 80 | 78 | 38 | 41 | 43 | 25 |
| Gross profit (loss) | 101 | 290 | 464 | 212 | 158 | 191 | 417 | 475 | 275 | 223 | 160 | 111 |
| Selling, general and administrative expenses | 628 | 1,413 | 1,572 | 2,294 | 2,870 | 5,543 | 2,219 | 1,581 | 1,578 | 2,284 | 1,406 | 975 |
| Operating profit (loss) | -527 | -1,123 | -1,108 | -2,083 | -2,712 | -5,351 | -1,802 | -1,106 | -1,303 | -2,061 | -1,246 | -864 |
| Interest income | 4 | 18 | 28 | 56 | 43 | 26 | 13 | 17 | 14 | 13 | 25 | 26 |
| Foreign exchange gains | 102 | 225 | 919 | - | - | - | 22 | - | 13 | 66 | 60 | 54 |
| Subsidy income | - | - | - | 15 | 80 | 24 | 11 | - | - | 65 | 70 | 46 |
| Miscellaneous income | - | - | - | - | - | - | - | - | - | 1 | 0 | 0 |
| Non-operating income | 106 | 244 | 948 | 71 | 142 | 58 | 50 | 17 | 27 | 145 | 156 | 126 |
| Share acquisition rights issuance costs | - | - | - | - | - | - | - | 9 | - | 5 | 6 | 10 |
| Share issuance costs | 10 | 211 | 8 | 0 | 3 | 0 | 17 | 33 | 1 | 0 | 0 | 0 |
| Bond issuance costs | - | - | - | 5 | - | - | - | 5 | - | 2 | 6 | - |
| Share acquisition rights issuance costs | - | - | - | - | - | - | - | 9 | - | 5 | 6 | 10 |
| Share issuance costs | 10 | 211 | 8 | 0 | 3 | 0 | 17 | 33 | 1 | 0 | 0 | 0 |
| Bond issuance costs | - | - | - | 5 | - | - | - | 5 | - | 2 | 6 | - |
| Miscellaneous losses | - | - | - | - | - | - | - | - | 2 | 2 | 3 | 1 |
| Non-operating expenses | 12 | 215 | 11 | 370 | 49 | 11 | 23 | 56 | 3 | 9 | 15 | 11 |
| Ordinary profit (loss) | -432 | -1,095 | -171 | -2,381 | -2,619 | -5,304 | -1,774 | -1,144 | -1,279 | -1,925 | -1,105 | -750 |
| Gain on sale of non-current assets | 0 | - | 0 | - | - | - | - | - | - | 0 | 5 | 1 |
| Gain on reversal of share acquisition rights | - | - | - | - | 9 | 33 | 23 | 2 | - | 56 | 27 | - |
| Profit on redemption of bonds | - | - | - | - | - | - | - | - | - | - | 39 | - |
| Gain on sale of investment securities | - | - | - | - | - | - | - | - | - | 5 | - | 42 |
| Extraordinary income | 0 | - | 0 | - | 9 | 33 | 23 | 94 | - | 61 | 71 | 44 |
| Loss on sale and retirement of non-current assets | - | 0 | 1 | 0 | 0 | 0 | 0 | - | 0 | 1 | 0 | 0 |
| Impairment losses | 50 | 16 | 34 | 153 | 62 | 141 | 53 | 4 | 1,553 | 15 | 7 | 71 |
| Loss on valuation of investment securities | - | - | - | - | - | - | - | 692 | - | - | 268 | - |
| Extraordinary losses | 50 | 16 | 34 | 153 | 62 | 141 | 53 | 956 | 1,553 | 15 | 275 | 71 |
| Loss on valuation of shares of subsidiaries and associates | - | - | - | - | - | - | - | - | - | - | 1 | - |
| Extraordinary losses | 50 | 16 | 34 | 153 | 62 | 141 | 53 | 956 | 1,553 | 15 | 275 | 71 |
| Profit (loss) before income taxes | -482 | -1,111 | -206 | -2,534 | -2,672 | -5,413 | -1,805 | -2,006 | -2,832 | -1,879 | -1,308 | -778 |
| Income taxes - current | 2 | 2 | 2 | 3 | 4 | 4 | 4 | 4 | 4 | 3 | 2 | 2 |
| Income taxes | - | - | - | - | - | - | - | - | - | - | 2 | 2 |
| Profit (loss) | - | - | -207 | -2,537 | -2,676 | -5,417 | -1,809 | -2,010 | -2,836 | -1,882 | -1,311 | -780 |
| Profit (loss) | - | - | -207 | -2,537 | -2,676 | -5,417 | -1,809 | -2,010 | -2,836 | -1,882 | -1,311 | -780 |
| Profit (loss) attributable to owners of parent | - | - | - | - | - | - | - | - | - | - | -1,311 | -780 |